Shenzhen Hepalink Pharmaceutical (9989): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 4,225 Hongkong Dollar | 5,756 Hongkong Dollar | 3,74 Hongkong Dollar |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 3,631 Hongkong Dollar | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 220.094.500 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 5.478.982,088 | 5.280.713,41 | 5.445.572,06 | 7.159.410,684 | 6.365.177,483 | 5.332.074,875 | 4.624.653,616 | 4.814.965,143 | 2.670.205,861 | 2.260.932,415 | 2.292.300 | 1.958.861,291 | 1.513.168,624 | 1.761.820,027 | 2.494.581,271 | 3.853.447,853 | 2.224.124,221 | 435.220,584 | 299.382,047 | 277.794,736 |
Cashflow aus operativer Geschäftstätigkeit | 1.712.950,492 | 2.194.132,237 | 398.215,676 | -756.612,526 | -6.629,32 | 37.283,625 | -227.601,568 | 667.869,389 | -407.116,942 | 346.072,249 | 893.706,767 | 912.803,849 | 420.968,576 | 473.890,043 | 1.405.212,177 | 354.864,042 | 355.806,224 | 40.127,576 | 13.847,46 | 71.658,307 |
▸ Operative Cashflow Marge | 31,26% | 41,55% | 7,31% | -10,57% | -0,1% | 0,7% | -4,92% | 13,87% | -15,25% | 15,31% | 38,99% | 46,6% | 27,82% | 26,9% | 56,33% | 9,21% | 16% | 9,22% | 4,63% | 25,8% |
Investitionsausgaben (CapEx) | 121.101,943 | 202.769,169 | 444.877,658 | 222.421,477 | 193.860,672 | 212.489,968 | 362.076,445 | 535.009,431 | 576.130,515 | 359.536,207 | 168.848,791 | 167.622,566 | 293.975,197 | 237.546,754 | 134.163,442 | 35.933,355 | 54.914,369 | 10.811,614 | 11.951,734 | 10.706,052 |
Cashflow aus Investitionstätigkeit | -872.749,019 | -415.048,186 | 1.221.569,303 | 249.839,601 | 719.928,13 | -2.173.763,86 | 1.702,845 | -544.303,128 | -1.206.598,364 | -273.016,549 | -1.655.921,581 | -2.812.373,121 | -406.641,399 | -237.479,344 | -141.211,642 | -35.932,705 | -54.914,369 | -10.729,114 | -11.431,734 | -10.876,052 |
Cashflow aus Finanzierungstätigkeit | -1.094.567,059 | -2.139.730,075 | -1.210.172,083 | 329.564,162 | -501.080,665 | 2.506.462,123 | -234.334,761 | -1.616.105,162 | 564.470,091 | 274.223,792 | 809.892,382 | -26.573,232 | -552.086,534 | -421.775,616 | -748.600 | 5.494.335,535 | -16.641,065 | 99.730,375 | -122.439,241 | 58.032,24 |
Freier Cashflow | 1.591.848,549 | 1.991.363,068 | -46.661,982 | -979.034,003 | -200.489,992 | -175.206,343 | -589.678,013 | 132.859,958 | -983.247,457 | -13.463,958 | 724.857,976 | 745.181,283 | 126.993,379 | 236.343,289 | 1.271.048,735 | 318.930,687 | 300.891,855 | 29.315,962 | 1.895,726 | 60.952,255 |
▸ Freie Cashflow Marge | 29,05% | 37,71% | -0,86% | -13,67% | -3,15% | -3,29% | -12,75% | 2,76% | -36,82% | -0,6% | 31,62% | 38,04% | 8,39% | 13,41% | 50,95% | 8,28% | 13,53% | 6,74% | 0,63% | 21,94% |
Ausgeschüttete Dividenden | -430.809,733 | -159.901,32 | -425.889,625 | -251.005,864 | -412.481,171 | -447.484,511 | -342.511,641 | -255.141,216 | -444.584,575 | -541.436,21 | -292.267,515 | -262.565,288 | -480.187,08 | -480.120 | -800.200 | -5.488,655 | -67.580,446 | -19.521,902 | -59.387,628 | -10.798,519 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | 3.538.287 | - | - | - | -472.996,132 | - | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.